Molecular imaging of gliomas

Area of Science:

• Neuro-oncology
• Molecular Imaging
• Radiochemistry

Background:

• Gliomas are aggressive brain tumors with poor prognoses despite conventional therapies.
• Effective treatment requires precise tumor characterization and monitoring of novel therapeutic strategies.
• Gene- and cell-based therapies offer promise but need robust methods for clinical implementation.

Purpose of the Study:

• To review the role of molecular and functional imaging in advancing glioma diagnostics and therapeutics.
• To highlight the importance of imaging endogenous and exogenous gene expression for glioma treatment.
• To discuss the current status and future perspectives of molecular imaging in managing gliomas.

Main Methods:

• Multi-modal radionuclide and magnetic resonance imaging techniques are central.
• Imaging of endogenous gene expression (e.g., transporters, kinases) for tumor characterization.
• Positron emission tomography (PET) for noninvasive monitoring of gene therapy efficacy.

Main Results:

• Molecular imaging allows precise localization, metabolic assessment, and identification of target tissues in gliomas.
• It aids in evaluating neuronal function and protecting healthy brain tissue during therapy.
• Imaging of both endogenous and exogenous gene expression is vital for translating research to clinical practice.

Conclusions:

• Molecular and functional imaging are essential for developing improved diagnostics and effective treatments for gliomas.
• Noninvasive imaging of gene expression provides critical insights into glioma biology and treatment response.
• Advancements in molecular imaging hold the potential to significantly improve the prognosis of this devastating disease.